IKZF1 and acute lymphoblastic leukemia: The experimental leukemia presented with all the hallmarks of Ph-like “IKZF1 plus” human BCP-ALL in patients including a Ph-like expression signature, the spontaneous acquisition of the genomic loss of IKZF1, and the loss of the cell cycle regulator CDKN2A30.